BNP Paribas Asset Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,752
Closed -$27K 2280
2025
Q4
$27K Buy
1,752
+325
+23% +$3.58K ﹤0.01% 1849
2025
Q3
$14K Buy
1,427
+458
+47% +$4.77K ﹤0.01% 1517
2025
Q2
$10K Buy
+969
New +$10.2K ﹤0.01% 1768

Other funds holding DVAX

BNP Paribas Asset Management's DVAX Position: Q1 2026 in Review

BNP Paribas Asset Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 1,752 shares — an estimated $27K sold.

BNP Paribas Asset Management first reported a position in DVAX in Q2 2025 and held it in 3 quarters. The position peaked at $27K in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • BNP Paribas Asset Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • BNP Paribas Asset Management sold 1,752 Dynavax Technologies shares in Q1 2026, an estimated $27K.
  • BNP Paribas Asset Management first reported a position in Dynavax Technologies in Q2 2025 and held it in 3 quarters.
  • BNP Paribas Asset Management's Dynavax Technologies position peaked at $27K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.